Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-13-012261
Filing Date
2013-07-29
Accepted
2013-07-29 19:46:02
Documents
1
Period of Report
2013-07-26

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 6543
  Complete submission text file 0001179110-13-012261.txt   7782
Mailing Address 249 E. GRAND AVE. SOUTH SAN FRANCISCO CA 94080
Business Address 249 E. GRAND AVE. SOUTH SAN FRANCISCO CA 94080 650-266-0000
ONYX PHARMACEUTICALS INC (Issuer) CIK: 0001012140 (see all company filings)

EIN.: 943154463 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address
Business Address
GRILLO LOPEZ ANTONIO J (Reporting) CIK: 0001235942 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-28298 | Film No.: 13993818